108
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      重组人纤维连接蛋白诱导的CIK细胞的生物学特性和对肺癌细胞株杀伤活性的体外研究 Translated title: Biological Characteristics and Antitumor Activity of CIK Cells Activated by Recombinant Human Fibronectin for Human Lung Cancer Cell Lines In Vitro

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          背景与目的

          CIK细胞是过继免疫治疗的重要手段之一,简化体外培养过程从而提高其增殖率和杀瘤活性仍是目前研究的一个热点课题。本研究观察重组人纤维连接蛋白(recombinant human fibronectin, RN)诱导CIK细胞的生物学特性,建立一种高效、简便的体外CIK细胞扩增方法。

          方法

          抽取10名健康人外周静脉血各50 mL,用淋巴细胞分离液分离单个核细胞,分别采用RN诱导法和传统方法培养CIK细胞,记录细胞增殖数;用流式细胞术测定免疫细胞表型和分泌IFN-γ、IL-4、穿孔素和颗粒酶B细胞的百分比;用MTT法测定CIK细胞对4种人肺癌细胞株的体外杀伤率。

          结果

          RN诱导的CIK细胞扩增倍数为传统方法的2.0倍-3.5倍,具有统计学差异( P < 0.05);RN诱导组和传统方法组CD3 +CD16 +CD56 +细胞绝对数分别增加了3 778倍和2 069倍;RN诱导组细胞中CD3 +CD8 +细胞比例明显高于传统方法组( P < 0.05);但CD3 +CD4 +细胞比例无统计学差异( P > 0.05);对4种肺癌细胞株的体外杀伤活性无统计学差异( P > 0.05)。RN诱导的CIK较诱导前:分泌IFN-γ的细胞比例明显增加;分泌IL-4的细胞比例略有降低;释放穿孔素、颗粒酶B的阳性细胞比例较诱导前增加。

          结论

          RN诱导法是一种高效、简便的体外扩增CIK方法,可以替代传统方法。

          Translated abstract

          Background and objective

          The CIK cell is one of the most important means of the adoptive cellular immunotherapy, and it is a hotspot of which to simplify its culture procedure and to promote its inhibition rate. The aim of this study is to observe the biological function of the CIK cells cultivated by the recombinant human fibronectin (RN) and to establish an effective and simple way of cells expansion.

          Methods

          We separated the mononuclear cells (PBMCs) in 50 mL peripheral blood from 10 healthy persons with density gradient centrifugation in the lymphocyte-separating medium, and the PBMCs were divided into two groups, of which were cultivated by RN-introduced and conventional method separately. Then we estimated the proliferation ability, and analyzed the immunologic type, IFN-γ, IL-4, perforin and granzyme B of them with flow cytometry. Besides that, we tested the inhibition rate of CIKs cells to four kinds of human lung cancer cell lines in vitro by MTT assay.

          Results

          The RN-induced group had a higher proliferation rate that was 2.0-3.5 times of the conventional group, and there was an obvious statistical difference between the two ( P < 0.05). The proliferation rates of CD3 +CD16 +CD56 +T cells in each group were 3 778 and 2 068 times of the initial number, respectively. There was also a higher percentage of CD3 +CD8 + T cells in RN-induced group ( P < 0.05), while the percentage of CD3 +CD4 +T cells had no significant statistical difference ( P > 0.05). We found a similar inhibition rate of the CIK cells to all this human lung cancer cell lines ( P > 0.05). The cells which secreted IFN–γ increased, while the cells which secreted IL-4 did not. The cells which secreted granzyme B and perforin were positive.

          Conclusion

          It is an effective and simple way to cultivate the CIK cells with RN, which should be adopted.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Four Functionally Distinct Populations of Human Effector-Memory CD8+ T Lymphocytes

          In humans, the pathways of memory and effector T cell differentiation remain poorly defined. We have dissected the functional properties of ex vivo effector-memory (EM) CD45RA-CCR7- T lymphocytes present within the circulating CD8+ T cell pool of healthy individuals. Our studies show that EM T cells are heterogeneous and are subdivided based on differential CD27 and CD28 expression into four subsets. EM(1) (CD27+CD28+) and EM(4) (CD27-CD28+) T cells express low levels of effector mediators such as granzyme B and perforin and high levels of CD127/IL-7Ralpha. EM(1) cells also have a relatively short replicative history and display strong ex vivo telomerase activity. Therefore, these cells are closely related to central-memory (CD45RA-CCR7+) cells. In contrast, EM(2) (CD27+CD28-) and EM(3) (CD27-CD28-) cells express mediators characteristic of effector cells, whereby EM(3) cells display stronger ex vivo cytolytic activity and have experienced larger numbers of cell divisions, thus resembling differentiated effector (CD45RA+CCR7-) cells. These data indicate that progressive up-regulation of cytolytic activity and stepwise loss of CCR7, CD28, and CD27 both characterize CD8+ T cell differentiation. Finally, memory CD8+ T cells not only include central-memory cells but also EM(1) cells, which differ in CCR7 expression and may therefore confer memory functions in lymphoid and peripheral tissues, respectively.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.

            The present study evaluated the clinical efficacy of chemotherapy in combination with cytokine-induced killer (CIK) biotherapy compared to the chemotherapy alone. Fifty-nine advanced non-small cell lung cancer (NSCLC) patients were randomly divided into two groups, group A (chemotherapy alone, including docetaxel 75 mg/m2, day 1; cisplatin, 25 mg/m2, days 1-4, tri-weekly) and group B (chemotherapy plus CIK cell transfusion). Autologous CIK cells were induced from the patients'peripheral mononuclear cells in vitro and separated by cytometry and then transfused back the patients. The host cellular immune function, clinical curative effects and quality of life (QOL) were examined and were compared between the two groups. The host immune function was enhanced and QOL was improved in the patients treated by chemotherapy plus CIK biotherapy compared to the patients treated by chemotherapy alone. The overall response rate (ORR) was 43.3% and 44.8% in groups A and B, respectively. The disease control rate (DCR) was higher in group B than in group A (89.7% vs. 65.5%, p = 0.030). The time to progression was 4.67 months (95% CI 3.98-6.02 months) in group A and 6.65 months (95% CI 4.70-7.30 months) in group B and the median survival time was 11.0 months (95% CI 7.88-14.1 months) in group A and 15.0 months (95% CI 11.04-18.96 months) in group B. Compared to patients in group A, the patients in group B had significantly longer progression-free survival (p = 0.042) and overall survival (p = 0.029). No severe side-effects occurred in the CIK cell transfusion patients. It was concluded that chemotherapy plus CIK cells has potential benefits compared to chemotherapy alone in patients suffering from advanced NSCLC and autologous CIK cell transfusion has no obvious side-effects.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.

              Previous studies of perforin expression and cytokine production in subsets of peripheral human CD45RA(-)CD8(+) T cells with different CD28/CD27 phenotypes showed that CD28(+)CD45RA(-)CD8(+) and CD27(+)CD45RA(-)CD8(+) T cells have characteristics of memory T cells, whereas CD28(-)CD45RA(-)CD8(+) and CD27(-)CD45RA(-)CD8(+) T cells have characteristics of both memory and effector T cells. However, the differentiation pathway from memory CD8(+) T cells into memory/effector CD8(+) T cells has not been completely clarified. We investigated this differentiation pathway using EBV- and human CMV (HCMV)-specific CD8(+) T cells. Three subsets of CD45RA(-)CD8(+) T cells were observed in both total CD8(+) T cells and EBV- or HCMV-specific CD8(+) T cells: CD27(+)CD28(+), CD27(+)CD28(-), and CD27(-)CD28(-). A significant number of the CD27(-)CD28(+) subset was observed in total CD8 T cells. However, this subset was barely detectable in EBV- or HCMV-specific CD8(+) T cells. Analysis of perforin expression and cytotoxic activity in the first three subsets suggested the following differentiation pathway: CD27(+)CD28(+)CD45RA(-)-->CD27(+)CD28(-)CD45RA(-)-->CD27(-)CD28(-)CD45RA(-). This was supported by the observation that the frequency of CCR5(+) cells and CCR7(+) cells decreased during this sequence. Analysis of CCR5 and CCR7 expression in the CD27(+)CD28(+) memory cell subset demonstrated the presence of three CCR5/CCR7 populations: CCR5(-)CCR7(+), CCR5(+)CCR7(+), and CCR5(+)CCR7(-). These findings suggested the following differentiation pathway: CD27(+)CD28(+)CD45RA(-) (CCR5(-)CCR7(+)-->CCR5(+)CCR7(+)-->CCR5(+)CCR7(-))-->CD27(+)CD28(-)CD45RA(-)-->CD27(-)CD28(-)CD45RA(-). The presence of a CD27(-)CD28(+) subset with a CCR5(+)CCR7(-) phenotype implies a specialized role for this subset in the differentiation of CD8(+) T cells.
                Bookmark

                Author and article information

                Contributors
                Journal
                Zhongguo Fei Ai Za Zhi
                Zhongguo Fei Ai Za Zhi
                ZGFAZZ
                Chinese Journal of Lung Cancer
                中国肺癌杂志编辑部 (天津市和平区南京路228号300020 )
                1009-3419
                1999-6187
                20 April 2010
                : 13
                : 4
                : 277-281
                Affiliations
                [ ] 110032 沈阳,中国医科大学附属第四医院生物治疗科 Department of Biotherapy, Fourth Affiliated Hospital of China Medical University, Shenyang 110032, China
                Author notes
                王士勇, Shiyong WANG, E-mail: sywang66@ 123456yahoo.com

                王士勇和杜微丽同为第一作者

                Shiyong WANG and Weili DU contributed equally to this paper

                Article
                zgfazz-13-4-277 R734.2
                10.3779/j.issn.1009-3419.2010.04.01
                6000431
                20677549
                932094a4-04e8-4545-935b-9f10ae5a07b6
                版权所有©《中国肺癌杂志》编辑部2010Copyright ©2010 Chinese Journal of Lung Cancer. All rights reserved.

                This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/

                History
                : 16 November 2009
                : 26 December 2009
                Funding
                Funded by: 教育部留学回国人员科研启动基金
                Award ID: 2004-527
                Funded by: a grant from the Project-sponsored by SRF for ROCS
                Award ID: 2004-527
                本研究受教育部留学回国人员科研启动基金(No.2004-527)资助
                This study was supported by a grant from the Project-sponsored by SRF for ROCS (to Shiyong WANG)(No.2004-527)
                Categories
                基础研究
                Basic Research

                纤维连接蛋白,细胞因子诱导的杀伤性细胞,cd8+t细胞亚群,fibronectin,cytokine induced killer (cik) cells,cd8+t cells subset

                Comments

                Comment on this article